The alpha and omega of galactosylceramides in T cell immune function

Journal of Biological Chemistry

Volumn 290, Issue 25, 2015, Pages 15365-15370

  Birkholz, Alysia M ^a,b   Howell, Amy R ^c   Kronenberg, Mitchell ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; IMMUNE SYSTEM; LIPIDS; T-CELLS;

GLYCOLIPIDS; GLYCOSPHINGOLIPIDS; IMMUNE FUNCTION; IMMUNE RESPONSE; NATURAL KILLER T CELL; WHITE BLOOD CELLS;

CYTOLOGY;

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; AGELASPHIN 9B; ALPHA GALACTOSYLCERAMIDE; ANTINEOPLASTIC AGENT; CD1D ANTIGEN; GALACTOSYLCERAMIDE; GLYCOSPHINGOLIPID; INTERLEUKIN 4; OMEGA GALACTOSYLCERAMIDE; SULFATIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ANTIGEN;

ALLERGY; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LIPID ANALYSIS; LYMPHOCYTE ACTIVATION; MAMMAL CELL; MICROBIOME; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; IMMUNOLOGY; NATURAL KILLER T CELL; PHYSIOLOGY;

SPHINGOIDEA; VERTEBRATA;

ANIMALS; ANTIGENS; GALACTOSYLCERAMIDES; HUMANS; IMMUNITY, CELLULAR; NATURAL KILLER T-CELLS;

EID: 84940093360     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R115.647057     Document Type: Article

References (56)

1. + cells: new clues to their origin, specificity, and function. J. Exp. Med. 182, 633-638
2. Schmidt, R. E., Murray, C., Daley, J. F., Schlossman, S. F., and Ritz, J. (1986) A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J. Exp. Med. 164, 351-356
3. Exley, M., Porcelli, S., Furman, M., Garcia, J., and Balk, S. (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor α chains. J. Exp. Med. 188, 867-876
4. + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int. 23, 94-100
5. + T cell populations. Int. Immunol. 7, 1157-1161
6. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 178, 1-16
7. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., and Van Kaer, L. (2004) NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237
8. Salio, M., Silk, J. D., Jones, E. Y., and Cerundolo, V. (2014) Biology of CD1-and MR1-restricted T cells. Annu. Rev. Immunol. 32, 323-366
9. Lahiri, S., and Futerman, A. H. (2007) The metabolism and function of sphingolipids and glycosphingolipids. Cell. Mol. Life Sci. 64, 2270-2284
10. Hannun, Y. A., and Obeid, L. M. (2011) Many ceramides. J. Biol. Chem. 286, 27855-27862
11. Degroote, S., Wolthoorn, J., and van Meer, G. (2004) The cell biology of glycosphingolipids. Semin. Cell Dev. Biol. 15, 375-387
12. Ilan, Y. (2009) α versus β: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells? Clin. Exp. Immunol. 158, 300-307
13. Terabe, M., and Berzofsky, J. A. (2014) The immunoregulatory role of Type I and Type II NKT cells in cancer and other diseases. Cancer Immunol. Immunother. 63, 199-213
14. Natori, T., Morita, M., Akimoto, K., and Koezuka, Y. (1994) Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron 50, 2771-2784
15. Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., and Fukushima, H. (1995) Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176-2187
16. Zajonc, D. M., and Kronenberg, M. (2007) CD1 mediated T cell recognition of glycolipids. Curr. Opin. Struct. Biol. 17, 521-529
17. East, J. E., Kennedy, A. J., and Webb, T. J. (2014) Raising the roof: the preferential pharmacological stimulation of Th1 and Th2 responses mediated by NKT cells. Med. Res. Rev. 34, 45-76
18. Sidobre, S., Hammond, K. J. L., Bénazet-Sidobre, L., Maltsev, S. D., Richardson, S. K., Ndonye, R. M., Howell, A. R., Sakai, T., Besra, G. S., Porcelli, S. A., and Kronenberg, M. (2004) The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. U.S.A. 101, 12254-12259
19. Facciotti, F., Ramanjaneyulu, G. S., Lepore, M., Sansano, S., Cavallari, M., Kistowska, M., Forss-Petter, S., Ni, G., Colone, A., Singhal, A., Berger, J., Xia, C., Mori, L., and De Libero, G. (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat. Immunol. 13, 474-480
20. Pei, B., Speak, A. O., Shepherd, D., Butters, T., Cerundolo, V., Platt, F. M., and Kronenberg, M. (2011) Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. J. Immunol. 186, 1348-1360
21. Brennan, P. J., Tatituri, R. V. V., Heiss, C., Watts, G. F. M., Hsu, F.-F., Veerapen, N., Cox, L. R., Azadi, P., Besra, G. S., and Brenner, M. B. (2014) Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction. Proc. Natl. Acad. Sci. U.S.A. 111, 13433-13438
22. Kain, L., Webb, B., Anderson, B. L., Deng, S., Holt, M., Constanzo, A., Zhao, M., Self, K., Teyton, A., Everett, C., Kronenberg, M., Zajonc, D. M., Bendelac, A., Savage, P. B., and Teyton, L. (2014) The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. Immunity 41, 543-554
23. Schmieg, J., Yang, G., Franck, R. W., and Tsuji, M. (2003) Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198, 1631-1641
24. Oki, S., Chiba, A., Yamamura, T., and Miyake, S. (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113, 1631-1640
25. Raphael, I., Nalawade, S., Eagar, T. N., and Forsthuber, T. G. (2014) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 10.1016/j.cyto.2014.09.011
26. Girardi, E., Maricic, I., Wang, J., Mac, T.-T., Iyer, P., Kumar, V., and Zajonc, D. M. (2012) Type II natural killer T cells use features of both innatelike and conventional T cells to recognize sulfatide self antigens. Nat. Immunol. 13, 851-856
27. Arora, P., Baena, A., Yu, K. O. A., Saini, N. K., Kharkwal, S. S., Goldberg, M. F., Kunnath-Velayudhan, S., Carreño, L. J., Venkataswamy, M. M., Kim, J., Lazar-Molnar, E., Lauvau, G., Chang, Y.-T., Liu, Z., Bittman, R., Al-Shamkhani, A., Cox, L. R., Jervis, P. J., Veerapen, N., Besra, G. S., and Porcelli, S. A. (2014) A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity 40, 105-116
28. Mallevaey, T., Clarke, A. J., Scott-Browne, J. P., Young, M. H., Roisman, L. C., Pellicci, D. G., Patel, O., Vivian, J. P., Matsuda, J. L., McCluskey, J., Godfrey, D. I., Marrack, P., Rossjohn, J., and Gapin, L. (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34, 315-326
29. Sullivan, B. A., Nagarajan, N. A., Wingender, G., Wang, J., Scott, I., Tsuji, M., Franck, R. W., Porcelli, S. A., Zajonc, D. M., and Kronenberg, M. (2010) Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14i NKT cells. J. Immunol. 184, 141-153
30. Girardi, E., and Zajonc, D. M. (2012) Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunol. Rev. 250, 167-179
31. Rossjohn, J., Pellicci, D. G., Patel, O., Gapin, L., and Godfrey, D. I. (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845-857
32. Aspeslagh, S., Nemcovic, M., Pauwels, N., Venken, K., Wang, J., Van Calenbergh, S., Zajonc, D. M., and Elewaut, D. (2013) Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection. J. Immunol. 191, 2916-2925
33. Tyznik, A. J., Farber, E., Girardi, E., Birkholz, A., Li, Y., Chitale, S., So, R., Arora, P., Khurana, A., Wang, J., Porcelli, S. A., Zajonc, D. M., Kronenberg, M., and Howell, A. R. (2011) Glycolipids that elicit IFN-γ-biased responses from natural killer T cells. Chem. Biol. 18, 1620-1630
34. Li, X., Fujio, M., Imamura, M., Wu, D., Vasan, S., Wong, C.-H., Ho, D. D., and Tsuji, M. (2010) Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc. Natl. Acad. Sci. U.S.A. 107, 13010-13015
35. Aspeslagh, S., Li, Y., Yu, E. D., Pauwels, N., Trappeniers, M., Girardi, E., Decruy, T., Van Beneden, K., Venken, K., Drennan, M., Leybaert, L., Wang, J., Franck, R. W., Van Calenbergh, S., Zajonc, D. M., and Elewaut, D. (2011) Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J. 30, 2294-2305
36. + T cells shape the formation of invariant NKT cells. J. Immunol. 184, 1218-1226
37. Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., and Blumberg, R. S. (2012) Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493
38. Wingender, G., Stepniak, D., Krebs, P., Lin, L., McBride, S., Wei, B., Braun, J., Mazmanian, S. K., and Kronenberg, M. (2012) Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 143, 418-428
39. Leslie, M. (2012) Gut microbes keep rare immune cells in line. Science 335, 1428-1428
40. Kinjo, Y., Wu, D., Kim, G., Xing, G.-W., Poles, M. A., Ho, D. D., Tsuji, M., Kawahara, K., Wong, C.-H., and Kronenberg, M. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525
41. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C., 3rd, Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N., Hoebe, K., Schneewind, O., Walker, D., Beutler, B., Teyton, L., Savage, P. B., and Bendelac, A. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529
42. Long, X., Deng, S., Mattner, J., Zang, Z., Zhou, D., McNary, N., Goff, R. D., Teyton, L., Bendelac, A., and Savage, P. B. (2007) Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat. Chem. Biol. 3, 559-564
43. Kinjo, Y., Pei, B., Bufali, S., Raju, R., Richardson, S. K., Imamura, M., Fujio, M., Wu, D., Khurana, A., Kawahara, K., Wong, C.-H., Howell, A. R., Seeberger, P. H., and Kronenberg, M. (2008) Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells. Chem. Biol. 15, 654-664
44. Wieland Brown, L. C., Penaranda, C., Kashyap, P. C., Williams, B. B., Clardy, J., Kronenberg, M., Sonnenburg, J. L., Comstock, L. E., Bluestone, J. A., and Fischbach, M. A. (2013) Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol. 11, e1001610
45. An, D., Oh, S. F., Olszak, T., Neves, J. F., Avci, F. Y., Erturk-Hasdemir, D., Lu, X., Zeissig, S., Blumberg, R. S., and Kasper, D. L. (2014) Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156, 123-133
46. Koch, U., and Radtke, F. (2011) Mechanisms of T cell development and transformation. Annu. Rev. Cell Dev. Biol. 27, 539-562
47. Issazadeh-Navikas, S. (2012) NKT cell self-reactivity: evolutionary master key of immune homeostasis? J Mol. Cell. Biol. 4, 70-78
48. Fox, L. M., Cox, D. G., Lockridge, J. L., Wang, X., Chen, X., Scharf, L., Trott, D. L., Ndonye, R. M., Veerapen, N., Besra, G. S., Howell, A. R., Cook, M. E., Adams, E. J., Hildebrand, W. H., and Gumperz, J. E. (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 7, e1000228
49. Parekh, V. V., Singh, A. K., Wilson, M. T., Olivares-Villagómez, D., Bezbradica, J. S., Inazawa, H., Ehara, H., Sakai, T., Serizawa, I., Wu, L., Wang, C. R., Joyce, S., and Van Kaer, L. (2004) Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids. J. Immunol. 173, 3693-3706
50. Ortaldo, J. R., Young, H. A., Winkler-Pickett, R. T., Bere, E. W., Jr., Murphy, W. J., and Wiltrout, R. H. (2004) Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCRbinding ceramides. J. Immunol. 172, 943-953
51. Pellicci, D. G., Clarke, A. J., Patel, O., Mallevaey, T., Beddoe, T., Le Nours, J., Uldrich, A. P., McCluskey, J., Besra, G. S., Porcelli, S. A., Gapin, L., Godfrey, D. I., and Rossjohn, J. (2011) Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat. Immunol. 12, 827-833
52. Brennan, P. J., Tatituri, R. V. V., Brigl, M., Kim, E. Y., Tuli, A., Sanderson, J. P., Gadola, S. D., Hsu, F.-F., Besra, G. S., and Brenner, M. B. (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat. Immunol. 12, 1202-1211
53. Zhou, D., Mattner, J., Cantu, C., 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., Teneberg, S., Wang, D., Proia, R. L., Levery, S. B., Savage, P. B., Teyton, L., and Bendelac, A. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789
54. Porubsky, S., Speak, A. O., Luckow, B., Cerundolo, V., Platt, F. M., and Gröne, H. J. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. U.S.A. 104, 5977-5982
55. Jahng, A. (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957
56. Blomqvist, M., Rhost, S., Teneberg, S., Löfbom, L., Osterbye, T., Brigl, M., Månsson, J. E., and Cardell, S. L. (2009) Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted Type II NKT cells. Eur. J. Immunol. 39, 1726-1735